DocMode Health Technologies Limited (NSE:DHTL)
India · Delayed Price · Currency is INR 29.40
-1.50 (-4.85%)
Sep 16, 2026, 10:36 AM IST
NSE:DHTL Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 255.16 | 417.73 | 400.07 | 328.78 | 124.23 |
Other Revenue | - | - | 0 | - | - |
| 255.16 | 417.73 | 400.07 | 328.78 | 124.23 | |
Revenue Growth | -38.92% | 4.41% | 21.68% | 164.66% | 74.95% |
Cost of Revenue | 199.04 | 361.22 | 313.92 | 9.24 | 18.3 |
Gross Profit | 56.12 | 56.51 | 86.16 | 319.54 | 105.94 |
Selling, General & Admin | 27.2 | 42.62 | 54.96 | 60.47 | 45.18 |
Other Operating Expenses | 18.34 | 12.9 | 12.35 | 221.61 | 41.9 |
Operating Expenses | 47.89 | 58.51 | 67.55 | 282.3 | 87.31 |
Operating Income | 8.23 | -2 | 18.61 | 37.24 | 18.62 |
Interest Expense | -9.65 | -18.7 | -14.85 | -10.17 | -2.49 |
Interest & Investment Income | - | 1.31 | 1.34 | 0.96 | 0.15 |
Currency Exchange Gain (Loss) | - | -0.29 | -0.07 | -0.14 | -0.1 |
Other Non Operating Income (Expenses) | - | 0.03 | -1.63 | -0.98 | -1.18 |
Pretax Income | -1.42 | -19.65 | 3.4 | 26.91 | 15 |
Income Tax Expense | -0.07 | 0.61 | 1.52 | 7.43 | 5.78 |
Net Income | -1.35 | -20.26 | 1.88 | 19.48 | 9.22 |
Net Income to Common | -1.35 | -20.26 | 1.88 | 19.48 | 9.22 |
Net Income Growth | - | - | -90.37% | 111.30% | 66.64% |
Shares Outstanding (Basic) | 3 | 3 | 3 | 2 | 2 |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 2 | 2 |
Shares Change | -0.18% | - | 37.07% | 30.43% | - |
EPS (Basic) | -0.43 | -6.45 | 0.60 | 8.50 | 5.24 |
EPS (Diluted) | -0.43 | -6.45 | 0.60 | 8.50 | 5.24 |
EPS Growth | - | - | -92.97% | 62.00% | 66.64% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 24.18 | 30.35 | -29.09 | -24.33 | -24.15 |
Free Cash Flow Per Share | 7.71 | 9.66 | -9.25 | -10.61 | -13.74 |
Gross Margin | 22.00% | 13.53% | 21.54% | 97.19% | 85.27% |
Operating Margin | 3.23% | -0.48% | 4.65% | 11.33% | 14.99% |
Profit Margin | -0.53% | -4.85% | 0.47% | 5.92% | 7.42% |
Free Cash Flow Margin | 9.48% | 7.27% | -7.27% | -7.40% | -19.44% |
EBITDA | 10.58 | 0.92 | 18.71 | 37.29 | 18.81 |
EBITDA Margin | 4.14% | 0.22% | 4.68% | 11.34% | 15.14% |
D&A For EBITDA | 2.35 | 2.92 | 0.1 | 0.05 | 0.18 |
EBIT | 8.23 | -2 | 18.61 | 37.24 | 18.62 |
EBIT Margin | 3.23% | -0.48% | 4.65% | 11.33% | 14.99% |
Effective Tax Rate | - | - | 44.77% | 27.60% | 38.55% |
Revenue as Reported | 269.11 | 427.03 | 401.43 | 329.74 | 124.38 |